Phase [tmco]    
Ii [aapp]    
RANDOM [resa]    
Control [ftcn]    
Trial [resa]    
Reduced [qlco]    
Serum alpha-fetoprotein [lbpr]    
patient [podg]    
Hepatitis C [dsyn]    
Cirrhosis [dsyn]    
Elevated alpha-fetoprotein [fndg]    
Models, Animal [anim]    
Hepatocellular carcinoma [neop]    
Deficiency [ftcn]    
Increase [qnco]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
Administration [ocac]    
Reduced [qlco]    
Hepatocellular carcinoma [neop]    
Aim [idcn]    
Trial [resa]    
To [qlco]    
Administration, Oral [topp]    
patient [podg]    
Hepatitis C [dsyn]    
Cirrhosis [dsyn]    
Decrease [qlco]    
Serum alpha-fetoprotein level [lbtr]    
Biomarker [clna]    
Hepatocellular carcinoma [neop]    
Risk [qlco]    
Hepatitis C [dsyn]    
This [euka]    
prospective [resa]    
RANDOM [resa]    
placebo-controlled [resa]    
DOUBLE BLIND [resa]    
Trial [resa]    
2-D [spco]    
g% [qnco]    
week [tmco]    
Compare [acty]    
placebo [topp]    
Subject [grup]    
Hepatitis C [dsyn]    
Cirrhosis [dsyn]    
MILDLY [idcn]    
Elevated alpha-fetoprotein [fndg]    
Serum [bdsu]    
Primary [qlco]    
Outcome [ftcn]    
Change [ftcn]    
baseline [bodm]    
week [tmco]    
secondary [neop]    
Outcome [ftcn]    
include [ftcn]    
Change [ftcn]    
Routine [qlco]    
Test [lbpr]    
Liver function [ortf]    
injuries [inpo]    
Biomarker [clna]    
Hepatocellular carcinoma [neop]    
Risk [qlco]    
Metabolite [bacs]    
Marker [clna]    
Oxidative Stress [comd]    
Quality [qlco]    
Life [idcn]    
One [qnco]    
TEN [dsyn]    
Subject [grup]    
RANDOM [resa]    
placebo [topp]    
Complete [qlco]    
treatment [ftcn]    
*Difference [qnco]    
Change [ftcn]    
week [tmco]    
Subject [grup]    
Receive [qlco]    
Compare [acty]    
placebo [topp]    
Change [ftcn]    
Marker [clna]    
Liver function [ortf]    
liver injury [inpo]    
Hepatitis C [dsyn]    
Viral [ftcn]    
Level [qlco]    
Not [ftcn]    
Different [qlco]    
Group [idcn]    
Not [ftcn]    
Change [ftcn]    
Marker [clna]    
Oxidative Stress [comd]    
Serum [bdsu]    
Level [qlco]    
Blood [tisu]    
Level [qlco]    
Increase [qnco]    
Subject [grup]    
Receive [qlco]    
Change [ftcn]    
Quality [qlco]    
Life [idcn]    
Not [ftcn]    
Group [idcn]    
Overall [inpr]    
Trial [resa]    
Not [ftcn]    
Find [fndg]    
treatment [ftcn]    
Improved [qlco]    
Serum alpha-fetoprotein [lbpr]    
Subject [grup]    
Advanced cirrhosis [dsyn]    
Hepatitis C [dsyn]    
MILDLY [idcn]    
Elevated alpha-fetoprotein [fndg]    
Not [ftcn]    
Test [lbpr]    
Liver function [ortf]    
injuries [inpo]    
Marker [clna]    
Oxidative Stress [comd]    
Antioxidant [phsu]    
Potential [qlco]    
[c] [qnco]    
AACR [pros]    
